Cite
HARVARD Citation
Newsome, P. et al. (2018). Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. Lancet gastroenterology and hepatology. pp. 25-36. [Online].